188 related articles for article (PubMed ID: 34552217)
1. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice.
Zhang QY; Xu SJ; Qian JC; Yang LB; Chen PQ; Wang Y; Hu X; Zhang YL; Luo W; Liang G
Acta Pharmacol Sin; 2022 Feb; 43(2):354-366. PubMed ID: 34552217
[TBL] [Abstract][Full Text] [Related]
2. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation.
Lin K; Luo W; Yang N; Su L; Zhou H; Hu X; Wang Y; Khan ZA; Huang W; Wu G; Liang G
Int Immunopharmacol; 2022 Nov; 112():109218. PubMed ID: 36116148
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice.
Zheng C; Huang L; Luo W; Yu W; Hu X; Guan X; Cai Y; Zou C; Yin H; Xu Z; Liang G; Wang Y
Cell Death Dis; 2019 Nov; 10(11):848. PubMed ID: 31699972
[TBL] [Abstract][Full Text] [Related]
5. Blockage of MyD88 in cardiomyocytes alleviates cardiac inflammation and cardiomyopathy in experimental diabetic mice.
Luo W; Wu G; Chen X; Zhang Q; Zou C; Wang J; Liu J; Chattipakorn N; Wang Y; Liang G
Biochem Pharmacol; 2022 Dec; 206():115292. PubMed ID: 36241098
[TBL] [Abstract][Full Text] [Related]
6. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
[TBL] [Abstract][Full Text] [Related]
7. 1,25(OH)
Liu P; Li F; Xu X; Li S; Dong X; Chen L; Bai B; Wang Y; Qiu M; Dong Y
Exp Mol Pathol; 2020 Jun; 114():104434. PubMed ID: 32240615
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
[TBL] [Abstract][Full Text] [Related]
9. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
Wang Y; Fang Q; Jin Y; Liu Z; Zou C; Yu W; Li W; Shan X; Chen R; Khan Z; Liang G
Br J Pharmacol; 2019 Jul; 176(14):2642-2657. PubMed ID: 30959575
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MyD88 by LM8 Attenuates Obesity-Induced Cardiac Injury.
Liu H; Jia W; Tang Y; Zhang W; Qi J; Yan J; Ding W; Cao H; Liang G; Zhu Z; Zheng H; Zhang Y
J Cardiovasc Pharmacol; 2020 Jul; 76(1):63-70. PubMed ID: 32398475
[TBL] [Abstract][Full Text] [Related]
11. A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responses.
Li L; Ding C; Zou C; Xiong Z; Zhu W; Qian J; Xu M; Zhang A; Liang G
Toxicol Appl Pharmacol; 2020 Dec; 409():115322. PubMed ID: 33171189
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy.
Luo W; Chen X; Ye L; Chen X; Jia W; Zhao Y; Samorodov AV; Zhang Y; Hu X; Zhuang F; Qian J; Zheng C; Liang G; Wang Y
J Ethnopharmacol; 2021 Mar; 268():113553. PubMed ID: 33152432
[TBL] [Abstract][Full Text] [Related]
13. HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4.
Yu J; Da J; Yu F; Yuan J; Zha Y
J Endocrinol Invest; 2024 Apr; 47(4):1015-1027. PubMed ID: 38409569
[TBL] [Abstract][Full Text] [Related]
14. ZnT8 Exerts Anti-apoptosis of Kidney Tubular Epithelial Cell in Diabetic Kidney Disease Through TNFAIP3-NF-κB Signal Pathways.
Chi Y; Zhang X; Liang D; Wang Y; Cai X; Dong J; Li L; Chi Z
Biol Trace Elem Res; 2023 May; 201(5):2442-2457. PubMed ID: 35871203
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
Gao P; Wu X; Shui H; Jia R
J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
[TBL] [Abstract][Full Text] [Related]
16. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
Zhang S; Xu L; Liang R; Yang C; Wang P
J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
[TBL] [Abstract][Full Text] [Related]
17. CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
Yang X; Luo W; Li L; Hu X; Xu M; Wang Y; Feng J; Qian J; Guan X; Zhao Y; Liang G
Toxicol Appl Pharmacol; 2021 Apr; 416():115465. PubMed ID: 33631230
[TBL] [Abstract][Full Text] [Related]
18. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
19. NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells.
Chen J; Peng H; Chen C; Wang Y; Sang T; Cai Z; Zhao Q; Chen S; Lin X; Eling T; Wang X
Life Sci; 2022 Dec; 311(Pt A):121142. PubMed ID: 36367498
[TBL] [Abstract][Full Text] [Related]
20. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
